Cargando…
Metabolome in progression to Alzheimer's disease
Mild cognitive impairment (MCI) is considered as a transition phase between normal aging and Alzheimer's disease (AD). MCI confers an increased risk of developing AD, although the state is heterogeneous with several possible outcomes, including even improvement back to normal cognition. We soug...
Autores principales: | Orešič, M, Hyötyläinen, T, Herukka, S-K, Sysi-Aho, M, Mattila, I, Seppänan-Laakso, T, Julkunen, V, Gopalacharyulu, P V, Hallikainen, M, Koikkalainen, J, Kivipelto, M, Helisalmi, S, Lötjönen, J, Soininen, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309497/ https://www.ncbi.nlm.nih.gov/pubmed/22832349 http://dx.doi.org/10.1038/tp.2011.55 |
Ejemplares similares
-
Metabolome in schizophrenia and other psychotic disorders: a general population-based study
por: Orešič, Matej, et al.
Publicado: (2011) -
Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2016) -
Improved Classification of Alzheimer's Disease Data via Removal of Nuisance Variability
por: Koikkalainen, Juha, et al.
Publicado: (2012) -
Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease
por: Wolz, Robin, et al.
Publicado: (2011) -
Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease
por: Jääskeläinen, Olli, et al.
Publicado: (2020)